RecruitingNCT07258784

RNA Sequencing of Discarded Tracheal Stenosis Tissue to Characterize Cellular and Molecular Pathogenesis


Sponsor

University of Maryland, Baltimore

Enrollment

10 participants

Start Date

Sep 11, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Benign tracheal stenosis is a rare but potentially life-threatening condition, typically resulting from fibroinflammatory scarring. It can be secondary to iatrogenic etiologies such as intubation or tracheostomy , as well as autoimmune diseases and being idiopathic. Patients typically undergoes endoscopic or surgical interventions to open up the airways. This project will analyze resected or biopsied tissue from patients with benign tracheal stenosis to define disease-specific RNA expression profiles.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria1

  • Patients with benign tracheal stenosis

Exclusion Criteria1

  • Malignancy. active infection

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBiopsy or surgery

The tissue will be obtained from biopsy or surgical resection. All the "intervention" will be performed for clinical needs. The tissue used in the study will be considered as discarded tissue


Locations(1)

University of Maryland

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07258784


Related Trials